Related Experiment Video
Updated: Feb 15, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Prognostic value of microRNA-155 in human carcinomas: An updated meta-analysis
Kangkang Liu1, Kun Zhao1, Lining Wang1
1Department of Urology, Tianjin Institute of Urology, The 2nd Hospital of Tianjin Medical University, Tianjin 300211, PR China.
Background:
miR-155 functions as an oncomiR or as an oncosuppressor-miR in human cancer. Although miR-155 has been researched in many cancers, its prognostic value is uncertain.
Methods:
We performed a literature search in up-to-date electronic databases including PubMed and Embase to obtain as many relevant articles as possible. Combined hazard ratios (HR) of miR-155 for outcome were analyzed.
Results:
A total of 24 papers researching different cancers were included in this meta-analysis. Combined HRs showed that miR-155 was significantly associated with a poorer OS with HR = 1.99 (1.34-2.96) (I-squared = 83.1%, P = 0.000). Combined HR of PFS/RFS/DFS was 1.95 (1.14-3.33) (I-squared = 75.9%, P = 0.000) and CSS/DSS was 2.50 (0.73-8.58) (I-squared = 87.7%, P = 0.000).
Conclusion:
Increased miR-155 expression was associated with poorer survival in human carcinoma and as such may be valuable in predicting outcome.
Insights
Increased microRNA-155 (miR-155) expression correlates with poorer survival in human cancers. This finding suggests miR-155 may serve as a valuable prognostic biomarker for various carcinoma outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Biomarker Discovery
Background:
- MicroRNA-155 (miR-155) exhibits dual roles as an oncomiR or oncosuppressor in human cancers.
- The prognostic significance of miR-155 across different cancer types remains uncertain.
Purpose of the Study:
- To systematically evaluate the prognostic value of miR-155 in human cancers.
- To determine the association between miR-155 expression levels and patient survival outcomes.
Main Methods:
- A comprehensive literature search was conducted in PubMed and Embase.
- Meta-analysis of combined hazard ratios (HR) was performed on data from 24 relevant studies.
Main Results:
- Elevated miR-155 expression was significantly linked to poorer overall survival (OS) (HR = 1.99).
- Increased miR-155 was also associated with reduced progression-free survival (PFS)/recurrence-free survival (RFS)/disease-free survival (DFS) (HR = 1.95).
- A trend towards poorer cancer-specific survival (CSS)/disease-specific survival (DSS) was observed (HR = 2.50).
Conclusions:
- Higher miR-155 expression is associated with adverse survival outcomes in human carcinoma.
- miR-155 demonstrates potential as a predictive biomarker for patient prognosis in cancer.
Related Concept Videos
MicroRNAs
MicroRNAs
Directing Effect of Substituents: meta-Directing Groups
meta-Directing Deactivators: –NO2, –CN, –CHO, –⁠CO2R, –COR, –CO2H
Pedigree Analysis
Biodiversity and Human Values

